- AIDS update. // Men's Health;Nov93, Vol. 8 Issue 8, p24
Discusses several developments in AIDS research. Testing to determine if a fat-based coating can minimize potentially toxic side effects of two chemotherapy drugs used to treat Kaposi's sarcoma; Early progress toward an anti-HIV vaccine; Clinical trials of a novel three-drug therapy for...
- Some aspects of the pathogenesis of HIV-1-associated kaposi's sarcoma. Gallo, Robert C. // JNCI: Journal of the National Cancer Institute;05/06/98 Supplement Monograph 23, Vol. 90 Issue 9, p55
Presents information on a study which focuses on kaposi's sarcoma. Investigation of the role of human immunodeficiency virus type 1 (HIV-1) infection; Discussion on whether KS is hyperplastic or neoplastic; Findings from the study.
- Human herpesvirus 8--the first human Rhadinovirus. Neipel, Frank; Albrecht, Jens-Christian; Fleckenstein, Bernard // JNCI: Journal of the National Cancer Institute;05/06/98 Supplement Monograph 23, Vol. 90 Issue 9, p73
Presents information on a study which focuses on the human herpesvirus 8 (HHV-8) of kaposi's sarcoma (KS)-associated herpesvirus as the first known human member of the genus Rhadionvirus. Where is Rhadionvirus found in KS; Detailed information on Rhadionvirus; Reference to the cloning and...
- Deletion and translocation involving chromosome 3(p14) in two tumorigenic Kaposi's Sarcoma cell... Popescu, Nicholas C.; Zimonjic, Drazen B. // JNCI: Journal of the National Cancer Institute;4/3/96, Vol. 88 Issue 7, p450
Investigates whether the chromosomal changes that occurred in neoplastic Kaposi's sarcoma (KS) cell lines were random or nonrandom. Description of materials and methods used in the study; Origin cell cultures; Cell culture conditions; Chromosome G-banding.
- Watch where you walk. Glausiusz, Josie // Discover;Apr94, Vol. 15 Issue 4, p26
Gives details on Kaposi's Sarcoma, a form of cancer. Physical description; Comparison with acquired immunodeficiency syndrome-related Kaposi; Statistical information on Kaposi's in gay men.
- Experimental treatments flourish for KS patients. Nelson, Nancy J. // JNCI: Journal of the National Cancer Institute;7/19/95, Vol. 87 Issue 14, p1052
Reports on developments in research knowledge on Kaposi's sarcoma (KS) discussed by clinical oncologists, scientists and AIDS activists during a meeting in Bethesda, Maryland. Vascular endothelial cells as the most likely cell of origin for KS; Development and testing of drugs against KS;...
- SHORT TAKES: San Francisco, CA. // Advocate;8/19/82, Issue 349, p23
Reports on the formation of the San Francisco, California-based Kaposi's Sarcoma Research and Education Foundation Inc. to support research and community education on disease related to immune system deficiencies.
- Killing of Sarcoma Cells by Proapoptotic Bcl-XS: Role of the BH3 Domain and Regulation by Bcl-XL. Mitra, Raj S; Benedict, Mary A; Qian, Dalong; Foreman, Kimberly E; Ekhterae, Daryoush; Nickoloff, Brian J; Nu�ez, Gabriel // Neoplasia;Sep2001, Vol. 3 Issue 5, p437
Kaposi's sarcoma (KS) is the most common tumor affecting AIDS patients with over 20% of these patients afflicted by this disease. Previous studies have demonstrated that KS tumor cells predominantly express the prosurvival protein Bcl-XL compared with Bcl-2. In the current study, we have used an...
- Relationship of Kaposi Sarcoma (KS)-Associated Herpesvirus Viremia and KS Disease in Zimbabwe. Ison, Michael G.; Hayden, Frederick G.; Kaiser, Laurent; Corey, Lawrence; Boeckh, Michael // Clinical Infectious Diseases;5/1/2003, Vol. 36 Issue 9, p1144
The relationship between Kaposi sarcoma--associated herpesvirus (KSHV) viremia and KS disease was investigated in 500 subjects who received treatment in Harare, Zimbabwe. Subjects were grouped by results of human immunodeficiency virus (HIV) type 1 serological tests, KS diagnosis, and KS...